RAPID WHOLE GENOME SEQUENCING Trademark

Trademark Overview

On Thursday, August 20, 2020, a trademark application was filed for RAPID WHOLE GENOME SEQUENCING with the United States Patent and Trademark Office. The USPTO has given the RAPID WHOLE GENOME SEQUENCING trademark a serial number of 90127700. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 11, 2023. This trademark is owned by Rady Children's Hospital Research Center. The RAPID WHOLE GENOME SEQUENCING trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Clinical rapid whole genome sequencing testing for medical purposes to enable the prevention, diagnosis and treatment of childhood genetic diseases
rapid whole genome sequencing

General Information

Serial Number90127700
Word MarkRAPID WHOLE GENOME SEQUENCING
Filing DateThursday, August 20, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesClinical rapid whole genome sequencing testing for medical purposes to enable the prevention, diagnosis and treatment of childhood genetic diseases

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 8, 2021
Primary Code044
First Use Anywhere DateFriday, August 14, 2020
First Use In Commerce DateFriday, August 14, 2020

Trademark Owner History

Party NameRady Children's Hospital Research Center
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSan Diego, CA 92111

Trademark Events

Event DateEvent Description
Tuesday, July 11, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, July 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 11, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 23, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 23, 2023FINAL REFUSAL E-MAILED
Monday, January 23, 2023FINAL REFUSAL WRITTEN
Wednesday, December 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 28, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 28, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 31, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 29, 2021NON-FINAL ACTION E-MAILED
Monday, November 29, 2021NON-FINAL ACTION WRITTEN
Saturday, October 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 29, 2021NON-FINAL ACTION E-MAILED
Thursday, April 29, 2021NON-FINAL ACTION WRITTEN
Thursday, April 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 7, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 7, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Wednesday, September 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 24, 2020NEW APPLICATION ENTERED

Related Keywords

sequencing genome whole rapid diagnosis prevention treatment childhood diseases genetic enable purposes